The 59.4% real-world pain responder rate from the use of inFoods® IBS closely mirrors the 59.6% result from the controlled trial-offering an unusual degree of consistency between controlled and ...
US indices tumble as tariff fears hit sentiment, with tech and blue chips sliding after IBM dumps, pushing markets toward key supports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results